Clinical Trial Update: Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Disc Degeneration [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and preliminary efficacy of IDCT for symptomatic lumbar degenerative disc disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• IDCT

Snippet

Sponsor: DiscGenics, Inc. | Conditions: Degenerative Disc Disease | Phase 1 | Status: COMPLETED